These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26474459)

  • 1. Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis.
    Lin C; Rezaee F; Waasdorp M; Shi K; van der Poll T; Borensztajn K; Spek CA
    Oncotarget; 2015 Nov; 6(34):35304-14. PubMed ID: 26474459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
    Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
    J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
    Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
    Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
    Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
    Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
    Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-laden macrophage-mediated paracrine profibrotic signaling induces lung fibroblast activation.
    Li Y; Du X; Hu Y; Wang D; Duan L; Zhang H; Zhang R; Xu Y; Zhou R; Zhang X; Zhang M; Liu J; Lv Z; Chen Y; Wang W; Sun Y; Cui Y
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C979-C993. PubMed ID: 39183565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
    Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.
    Bardou O; Menou A; François C; Duitman JW; von der Thüsen JH; Borie R; Sales KU; Mutze K; Castier Y; Sage E; Liu L; Bugge TH; Fairlie DP; Königshoff M; Crestani B; Borensztajn KS
    Am J Respir Crit Care Med; 2016 Apr; 193(8):847-60. PubMed ID: 26599507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury.
    Ballinger MN; Newstead MW; Zeng X; Bhan U; Mo XM; Kunkel SL; Moore BB; Flavell R; Christman JW; Standiford TJ
    J Immunol; 2015 Feb; 194(4):1894-904. PubMed ID: 25595781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High endogenous activated protein C levels attenuates bleomycin-induced pulmonary fibrosis.
    Lin C; von der Thüsen J; Isermann B; Weiler H; van der Poll T; Borensztajn K; Spek CA
    J Cell Mol Med; 2016 Nov; 20(11):2029-2035. PubMed ID: 27295971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis.
    Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
    Mol Med; 2015 Jun; 21(1):576-83. PubMed ID: 26147947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profibrotic role of WNT10A via TGF-β signaling in idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Izumi H; Ishimoto H; Yamada S; Nakao H; Hanaka T; Ogoshi T; Noguchi S; Mukae H
    Respir Res; 2016 Apr; 17():39. PubMed ID: 27071460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis.
    Duitman J; Ruela-de-Sousa RR; Shi K; de Boer OJ; Borensztajn KS; Florquin S; Peppelenbosch MP; Spek CA
    Mol Med; 2014 Sep; 20(1):410-6. PubMed ID: 24842054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206
    Wang J; Xu L; Xiang Z; Ren Y; Zheng X; Zhao Q; Zhou Q; Zhou Y; Xu L; Wang Y
    Cell Death Dis; 2020 Feb; 11(2):136. PubMed ID: 32075954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
    Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
    Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.
    Pedroza M; Le TT; Lewis K; Karmouty-Quintana H; To S; George AT; Blackburn MR; Tweardy DJ; Agarwal SK
    FASEB J; 2016 Jan; 30(1):129-40. PubMed ID: 26324850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
    Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
    Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.
    Scotton CJ; Krupiczojc MA; Königshoff M; Mercer PF; Lee YC; Kaminski N; Morser J; Post JM; Maher TM; Nicholson AG; Moffatt JD; Laurent GJ; Derian CK; Eickelberg O; Chambers RC
    J Clin Invest; 2009 Sep; 119(9):2550-63. PubMed ID: 19652365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.